Skip to main content
Log in

Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia

  • Original Articles
  • Oral Methotrexate
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Serum methotrexate levels were measured for 5 h after oral intake in 11 children with acute lymphoblastic leukaemia. The curves obtained with the child's regular dose of methotrexate varied widely, and were independent of the doses used. Peak levels were found in samples taken up to 3 h after ingestion, and ranged from 300 to 1250 ng/ml. In the doses used, methotrexate toxicity was present in one of the eleven children, and was associated with a delayed peak and a high 5-h methotrexate level. Individual drug metabolism could be an important factor in the response to treatment, and needs to be evaluated in the assessment of protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aherne, G. W., Piall, E. M., Marks, V.: Development and application of a radioimmunoassay for methotrexate. Br. J. Cancer 36, 608–617 (1977)

    Google Scholar 

  2. Bender, R. A., Bleyer, W. A., Frisby, S. A., Oliverio, V. T.: Alteration of methotrexate uptake in human leukaemia cells by other agents. Cancer Res. 35, 1305–1313 (1975)

    Google Scholar 

  3. Capizzi, R. L.: Improvement in the therapeutic index of methotrexate (NSC-740) by l-asparaginase (NSC-109229). Cancer Chemother. Rep. 6, 37–41 (1975)

    Google Scholar 

  4. Chessells, J. M., Hardisty, R. M., Rapson, N. T., Greaves, M. F.: Acute lymphoblastic leukaemia in children: Classification and prognosis. Lancet 1977 II, 1307–1309

    Google Scholar 

  5. Craft, A. W., Kay, H. M., Lawson, D. N., McElwain, T. J.: Methotrexate induced malabsorption in children with acute lymphoblastic leukaemia. Br. Med. J. 1977 II, 151–152

    Google Scholar 

  6. Goldie, J. H., Price, L. A., Harrap, K. R.: Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. Eur. J. Cancer 8, 409–414 (1972)

    Google Scholar 

  7. Haghbin, M., Tan, C. C., Clarkson, B. D., Mike, V., Burchenal, J. H., Murphy, M. L.: Intensive chemotherapy in children with acute lymphoblastic leukaemia (L-2 protocol). Cancer 33, 1491–1498 (1974)

    Google Scholar 

  8. Hardisty, R. M., Till, M. M.: Acute leukaemia 1959–1964: Factors affecting prognosis. Arch. Dis. Child. 43, 107–115 (1968)

    Google Scholar 

  9. Harrap, K. R., Hill, B. T., Furness, M. E., Hart, L. I.: Mechanism of action of methotrexate: Intrinsic and acquired drug resistance. Ann. N.Y. Acad. Sci. 186, 312–324 (1971)

    Google Scholar 

  10. Hill, B. T., Baserga, R.: The cell cycle and its significance for cancer treatment. Cancer Treat. Rev. 2, 159–175 (1975)

    Google Scholar 

  11. Huffman, D. H., Wan, S. H., Azarnoff, D. L., Hoogstraten, B.: Pharmacokinetics of methotrexate. Clin. Pharmacol. Ther. 14, 572–579 (1973)

    Google Scholar 

  12. Hustu, H. O., Aur, R. J. A., Verzosa, M. S., Simone, J. V., Pinkel, D.: Prevention of central nervous system leukaemia by irradiation. Cancer 32, 585–597 (1973)

    Google Scholar 

  13. McLennan, I. C. M., Peto, J., Kay, H. E. M.: Analysis of treatment in childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation. Br. J. Cancer 36, 625–633 (1977)

    Google Scholar 

  14. Mauer, A. M., Simone, J. V.: The current status of the treatment of childhood acute lymphoblastic leukaemia. Cancer Treat. Rev. 3, 17–41 (1976)

    Google Scholar 

  15. Medical Research Council: Treatment of acute lymphoblastic leukaemia: Effect of “prophylactic” therapy against central nervous system leukaemia. Br. Med. J. 1973 II, 381–384

    Google Scholar 

  16. Pinkel, D., Hernandez, K., borella, L., Holton, C., Aur, R., Samoy, G., Pratt, C.: Drug dosage and remission duration in childhood lymphocytic leukaemia. Cancer 27, 247–256 (1971)

    Google Scholar 

  17. Sheehy, P. F., Fried, J., Dowling, M. D., Clarkson, B. D.: Studies of cellular proliferation in human leukaemia. Cancer 36, 203–210 (1975)

    Google Scholar 

  18. Simone, J., Aur, R. J. A., Hustu, H. O., Pinkel, D.: “Total Therapy” studies of acute lymphocytic leukaemia in children. Cancer 30, 1488–1494 (1972)

    Google Scholar 

  19. Spiers, A. S. D., Roberts, P. D., Marsh, G. W., Parekh, S. J., Franklin, A. J., Galton, D. A. G., Szur, Z. L., Paul, E. A., Husband, P., Wiltshaw, E.: Acute lymphoblastic leukaemia: clinical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen). Br. Med. J. 1974 IV, 614–617

  20. Wan, S. H., Huffman, D. H., Azarnoff, D. L., Stephans, R., Hoogstraten, B.: Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res. 34, 3487–3491 (1974)

    Google Scholar 

  21. Young, R. C., Chabner, B. A.: An in vivo method for monitoring differential effects of chemottherapy on target tissues in animals and man: correlation with plasma pharmacokinetics. J. Clin. Invest. 52, 92a (1973)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kearney, P.J., Light, P.A., Preece, A. et al. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother. Pharmacol. 3, 117–120 (1979). https://doi.org/10.1007/BF00254982

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254982

Keywords

Navigation